Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Journal article |
| Vydáno: |
2001
|
| _version_ | 1826288277528772608 |
|---|---|
| author | Croucher, P Hijzen, A Shipman, C Perry, M Lippitt, J Green, J Van Camp, B Vanderkerken, K |
| author_facet | Croucher, P Hijzen, A Shipman, C Perry, M Lippitt, J Green, J Van Camp, B Vanderkerken, K |
| author_sort | Croucher, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T02:11:17Z |
| format | Journal article |
| id | oxford-uuid:a0bca79a-74ee-4a4c-812c-7936d1d2a9a4 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T02:11:17Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | oxford-uuid:a0bca79a-74ee-4a4c-812c-7936d1d2a9a42022-03-27T02:07:36ZZoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a0bca79a-74ee-4a4c-812c-7936d1d2a9a4Symplectic Elements at Oxford2001Croucher, PHijzen, AShipman, CPerry, MLippitt, JGreen, JVan Camp, BVanderkerken, K |
| spellingShingle | Croucher, P Hijzen, A Shipman, C Perry, M Lippitt, J Green, J Van Camp, B Vanderkerken, K Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title | Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title_full | Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title_fullStr | Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title_full_unstemmed | Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title_short | Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. |
| title_sort | zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma |
| work_keys_str_mv | AT croucherp zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT hijzena zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT shipmanc zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT perrym zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT lippittj zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT greenj zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT vancampb zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma AT vanderkerkenk zoledronicacidinhibitsthedevelopmentofosteolyticbonediseaseandincreasesdiseasefreesurvivalinamurinemodelofmultiplemyeloma |